
Premier PINC
Quarterly report 2025-Q3
added 11-04-2025
Premier Operating Income 2011-2026 | PINC
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Premier
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.12 M | 127 M | 244 M | 260 M | 257 M | 374 M | 369 M | 540 M | 318 M | 266 M | 266 M | 302 M | 373 M | 322 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 540 M | 1.12 M | 287 M |
Quarterly Operating Income Premier
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.9 M | 33.8 M | -92.8 M | 35.3 M | -77.6 M | 62.9 M | 58.3 M | 62.6 M | 88.2 M | 58.5 M | 147 M | 56.8 M | 78 M | 72.3 M | 150 M | 66.2 M | 70 M | 57 M | 70 M | 57 M | 121 M | 84 M | 121 M | 84 M | 101 M | 94.6 M | 98.8 M | 92.7 M | 265 M | 70.5 M | 265 M | 70.5 M | 74.6 M | 72.5 M | 74.6 M | 72.5 M | 70.1 M | 68.3 M | 70.1 M | 68.3 M | 65.7 M | 66.1 M | 65.7 M | 66.1 M | 61.2 M | 109 M | 61.2 M | 100 M | 84.1 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 265 M | -92.8 M | 77.5 M |
Operating Income of other stocks in the Health information services industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
American Well Corporation
AMWL
|
-105 M | $ 5.46 | -0.91 % | $ 87.6 M | ||
|
Accolade
ACCD
|
-46.8 M | - | 0.29 % | $ 206 M | ||
|
Cerner Corporation
CERN
|
708 M | - | - | $ 27.9 B | ||
|
Computer Programs and Systems
CPSI
|
-42.6 M | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
-23 M | - | - | $ 2.94 B | ||
|
iCAD
ICAD
|
-6.27 M | - | - | $ 102 M | ||
|
1Life Healthcare
ONEM
|
-243 M | - | - | $ 3.37 B | ||
|
Akerna Corp.
KERN
|
-17.7 M | - | - | $ 161 M | ||
|
HealthStream
HSTM
|
21.3 M | $ 22.0 | -0.23 % | $ 668 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
77.2 M | - | -10.39 % | $ 886 M | ||
|
Evolent Health
EVH
|
3.64 M | $ 3.58 | 0.7 % | $ 335 M | ||
|
HealthEquity
HQY
|
118 M | $ 83.61 | 3.03 % | $ 7.15 B | ||
|
MTBC
MTBC
|
9.12 M | - | -0.58 % | $ 51.7 M | ||
|
Change Healthcare
CHNG
|
137 M | - | - | $ 9.03 B | ||
|
Omnicell
OMCL
|
337 K | $ 40.9 | -1.53 % | $ 1.88 B | ||
|
GoodRx Holdings
GDRX
|
65.8 M | $ 2.29 | 5.05 % | $ 883 M | ||
|
Health Catalyst
HCAT
|
-69.8 M | $ 1.97 | 1.03 % | $ 119 M | ||
|
So-Young International
SY
|
-624 M | $ 2.92 | 1.39 % | $ 232 M | ||
|
Progyny
PGNY
|
15.8 M | $ 17.57 | -1.26 % | $ 1.51 B | ||
|
Teladoc Health
TDOC
|
-263 M | $ 5.18 | 0.88 % | $ 913 M | ||
|
10x Genomics
TXG
|
-265 M | $ 22.15 | -0.98 % | $ 2.6 B | ||
|
Veeva Systems
VEEV
|
429 M | $ 201.0 | 6.64 % | $ 32.3 B | ||
|
R1 RCM
RCM
|
146 M | - | - | $ 3.81 B | ||
|
SCWorx Corp.
WORX
|
-1.26 M | $ 0.13 | -2.08 % | $ 190 K | ||
|
NantHealth
NH
|
-51.3 M | - | -46.64 % | $ 10.4 M | ||
|
OptimizeRx Corporation
OPRX
|
-26.4 M | $ 7.93 | 0.7 % | $ 136 M | ||
|
NextGen Healthcare
NXGN
|
12.8 M | - | - | $ 1.6 B | ||
|
Phreesia
PHR
|
-136 M | $ 12.79 | 1.35 % | $ 698 M | ||
|
Schrödinger
SDGR
|
-167 M | $ 12.96 | -1.22 % | $ 952 M | ||
|
Zhongchao
ZCMD
|
-341 K | $ 1.8 | 7.78 % | $ 9.37 M | ||
|
Signify Health
SGFY
|
9.5 M | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
-8.03 M | - | - | $ 21.4 M | ||
|
Tabula Rasa HealthCare
TRHC
|
-69 M | - | - | $ 255 M |